ACS Medicinal Chemistry Letters · 2010 · 103 citations · 30 references
PharmacyMedicinal ChemistryMolecular BiologyCancer PharmacologyDrug DiscoveryMolecular OncologyAllosteric Drug DesignAllosteric RecognitionAllosteric RegulationCancer Cell SignalingSignal Transduction In CancerTargeted Cancer TherapyAllosteric Modulator BindingAllosteric PathwaysC-terminal Domain StructureCancer Signaling PathwaysDomain-protein InteractionsProtein Binding In OncologyTherapeutic Modulation
Herein we show that San A-amide, a structurally unique molecule, influences a subset of cancer-related pathways involving Hsp90. We show that San A-amide specifically binds to the N-middle domain of Hsp90 allosterically disrupts the binding of proteins thought to interact with the Hsp90 C-terminal domain, while having no effect on an N-terminal domain client protein. This unique mechanism suggests that San A-amide is a potential tool for studying C-terminal binding proteins of Hsp90 as well as a promising lead in the development of new cancer therapeutics.
30
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Adeela Kamal, Lia Thao, John Sensintaffar et al. · Nature · 2003 · 1.4K citations
Medicine, Oncology, Pharmacology +10
Role of the Myosin Assembly Protein UNC-45 as a Molecular Chaperone for Myosin
José M. Barral, Alex H. Hutagalung, Achim Brinker et al. · Science · 2002 · 253 citations